Management of Osteoporosis in Liver Transplant Recipients |
Choi, Hojeong
(Department of Pharmacy, Seoul National University Bundang Hospital)
Kim, Boram (Department of Pharmacy, Seoul National University Bundang Hospital) Kim, Yoonhee (Department of Pharmacy, Seoul National University Bundang Hospital) Lee, Jungwha (Department of Pharmacy, Seoul National University Bundang Hospital) Lee, Eunsook (Department of Pharmacy, Seoul National University Bundang Hospital) Lee, Euni (College of Pharmacy & Research Institute of Pharmaceutical Science, Seoul National University) Cho, Jai Young (Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital) Choi, YoungRok (Department of Surgery, Seoul National University College of Medicine, Seoul National University Hospital) |
1 | Lee Y, Shin CS. Post-transplantation osteoporosis. J Korean Soc Transplant 2011;25(4):239-44. DOI |
2 | Desai R, Jamieson NV, Gimson AE, et al. Quality of life up to 30 years following liver transplantation. Liver Transpl 2008;14(10):1473-9. DOI |
3 | Sheiner PA, Magliocca JF, Bodian CA, et al. Long-term medical complications in patients surviving > or =5 years after liver transplant. Transplantation 2000;69(5):781-9. DOI |
4 | Navasa M, Forns X, Sanchez V, et al. Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation. J hepatol 1996;25(2):129-34. DOI |
5 | van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 2000;39(12):1383-9. DOI |
6 | Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids potential mechanisms of their deleterious effects on bone. J Clin invest 1998;102(2):274-82. DOI |
7 | Kanda J, Izumo N, Furukawa M, et al. Effects of the calcineurin inhibitors cyclosporine and tacrolimus on bone metabolism in rats. Biomed Res 2018;39(3):131-9 DOI |
8 | Stern PH. The calcineurin-NFAT pathway and bone: intriguing new findings. Mol interv 2006;6(4):193-6. DOI |
9 | Ebeling PR. Approach to the patient with transplantation-related bone loss. J Clin Endocrinol Metab 2009;94(5):1483-90. DOI |
10 | Kanis JA, Hans D, Cooper C, et al. Interpretation and use of FRAX in clinical practice. Osteoporos int 2011;22(9):2395-411. DOI |
11 | Young AL, Rao SK, Cheng LL, Wong AK, Leung AT, Lam DS. Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience. Eye 2002;16(3):304-8. DOI |
12 | Kanis JA, McCloskey EV, Johansson H, Oden A, Strom O, Borgstrom F. Development and use of in osteoporosis. Osteoporos int 2010;21(2):407-13. DOI |
13 | McCloskey EV, Oden A, Harvey NC, et al. A meta analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 2016;31(5):940-8. DOI |
14 | Health insurance review assessment service. Osteoporosis treatment. 2018. Available from: https://www.hira.or.kr/rd/insuadtcrtr/InsuAdtCrtrPopup.do?mtgHmeDd=20181201&sno=1&mtgMtrRegSno=0008. Accessed December 1, 2018. |
15 | Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int 2003;14(8):617-30. DOI |
16 | Camacho PM, Petak SM, Binkley N, et al. American association of clinical endocrinologists and american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2016. Endocr Pract 2016;22(Suppl 4):1-42. |
17 | Naylor KL, Leslie WD, Hodsman AB, Rush DN, Garg AX. FRAX predicts fracture risk in kidney transplant recipients. Transplantation 2014;97(9):940-5. DOI |
18 | Park SY, Gong HS, Kim KM, et al. Korean guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. J Bone Metab. 2018;25(4):195-211. DOI |
19 | Lucey MR, Terrault N, Ojo L, et al. Long term management of the successful adult liver transplant: 2012 practice guideline by the american association for the study of liver diseases and the american society of transplantation. Liver Transpl 2013;19(1):3-26. DOI |
20 | Sullivan SD, Lehman A, Nathan NK, Thomson CA, Howard BV. Age of menopause and fracture risk in post-menopausal women randomized to calcium+vitamin D, hormone therapy, or the combination: results from the womens health initiative clinical trials. Menopause 2017;24(4):371-378 DOI |
21 | Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos int 2007;18(4):427-44. DOI |
22 | Jung JW, Kim H, Park MS, et al. The characteristics and treatment of bone loss after liver transplant. J Korean Soc Transplant 2011;25(4):249-56. DOI |
23 | Brunova J, Kratochvilova S, Stepankova J. Osteoporosis therapy with denosumab in organ transplant recipients. Front Endocrinol (Lausanne) 2018;9:162. DOI |
24 | Mok CC, Ho LY, Ma KM. Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial. Bone 2015;75:222-8. DOI |